Nifty Midcap 100 59597.8 (-0.20)
Nifty Pharma 22562.3 (-0.47)
Nifty 50 25732.3 (-0.22)
SENSEX 83627.69 (-0.30)
Nifty Bank 59578.8 (0.22)
Nifty IT 38236.55 (0.65)
Nifty Next 50 68522 (-0.26)
Nifty Smallcap 100 17295.8 (0.60)
NIKKEI 225 53549.16 (3.10)
HANG SENG 26848.47 (0.90)
S&P 6983.98 (-0.20)
11-Nov-2025
OP down 28.72%
'On consolidated basisQuarter ended September 2025 compared with Quarter ended September 2024. Net sales (including other operating income) of Emami has declined 10.34% to Rs 798.51 crore. Sales of Within India segment has gone down 14.86% to Rs 618.32 crore (accounting for 77.43% of total sales). Sales of Outside India segment has gone up 9.66% to Rs 180.19 crore (accounting for 22.57% of total sales). Operating profit margin has declined from 28.12% to 22.36%, leading to 28.72% decline in operating profit to Rs 178.53 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 22.15% to 23.14%. Purchase of finished goods cost rose from 10.61% to 11.42%. Employee cost increased from 12.05% to 13.99%. Other expenses rose from 28.43% to 30.86%. Selling and administration expenses rose from 15.56% to 18.05%.
Other income f...
(13-Jan-2026)
Net profit jumps 20%, VNB improves in Q3FY2026
Net up 33% on strong operating show
Revenue up 13.3% YoY to Rs 33872 crore in Q3FY2026
Revenue up 4.9% YoY to Rs 67087 crore in Q3FY2026
Results-Analysis (11-Nov-2025)
Results-Analysis (01-Aug-2025)
Sales remain flat, while NP increased 7.61%
Results-Analysis (28-Jan-2025)
OP up 7.57%
Results-Analysis (08-Nov-2024)
NP up 19.14%